Literature DB >> 27993826

Minimal change disease associated with malignant pleural mesothelioma: case report and review of the literature.

Halil Yildiz1, Stoian Ioana Andreea2, Delphine Hoton3, Jean Cyr Yombi4.   

Abstract

A 77-year-old man with a history of asbestos exposure was admitted to our internal medicine division for generalised weakness, fatigue, loss of weight, night sweats and difficulty for breathing since 3 months. Clinical examination revealed left fine crackles and bilateral leg oedema. Blood test showed elevated C reactive protein level at 142 mg/L, lactate dehydrogenase level at 421 UI, creatinine level at 5.75 mg/dL. Serum albumin level at 30 g/L, urinalysis showed significant proteinuria at 6.4 g/L. Chest X-ray showed left pleural effusion. Renal ultrasonography was normal. Thoracic CT and positron emission tomography showed mediastinal enlargement with lymphadenopathies and left pleural effusion and thickening. A pleural biopsy showed features compatible with malignant epithelioid mesothelioma. Renal biopsy showed minimal change disease and acute tubular necrosis. A diagnosis of malignant mesothelioma associated with minimal change disease and acute tubular necrosis secondary was then made. Given the poor general condition, palliative care was initiated and the patient died from respiratory failure 3 months later. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27993826      PMCID: PMC5174885          DOI: 10.1136/bcr-2016-217958

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Malignant pleural mesothelioma with associated minimal change disease and acute renal failure.

Authors:  Jordan Y Z Li; Tuck Y Yong; Bryone J Kuss; Sonja Klebe; Dusan Kotasek; Jeffrey A J Barbara
Journal:  Ren Fail       Date:  2010       Impact factor: 2.606

2.  Focal and segmental glomerulosclerosis associated with malignant mesothelioma.

Authors:  M Absy; B Gazzawi; E Amoah
Journal:  Nephron       Date:  1992       Impact factor: 2.847

3.  Nephrotic syndrome and mesenteric infarction secondary to metastatic mesothelioma.

Authors:  C K Farmer; D J Goldsmith
Journal:  Postgrad Med J       Date:  2001-05       Impact factor: 2.401

4.  Immunoglobulin A nephropathy associated with mesothelioma.

Authors:  Adewale Fawole; Hamed Daw; Harris Taylor; Arash Rashidi
Journal:  WMJ       Date:  2012-02

Review 5.  The treatment of minimal change disease in adults.

Authors:  Jonathan Hogan; Jai Radhakrishnan
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

6.  Pleural mesothelioma and membranous nephropathy.

Authors:  K Galesic; B Bozic; R Heinzl; M Scukanec-Spoljar; V Bozikov
Journal:  Nephron       Date:  2000-01       Impact factor: 2.847

7.  Membranous glomerulonephritis associated with diffuse malignant pleural mesothelioma: report of a case.

Authors:  K Sakamoto; H Suzuki; T Jojima
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

8.  [Subacute cerebellar degeneration and pleural mesothelioma. Report of a case].

Authors:  D Tassinari; S Sartori; V Arcangeli; G Drudi; I Panzini; G Pasini; A Ravaioli
Journal:  Recenti Prog Med       Date:  2000-06

9.  Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndrome.

Authors:  Cecilia Bech; Jens Benn Sørensen
Journal:  J Thorac Oncol       Date:  2008-11       Impact factor: 15.609

Review 10.  Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

Authors:  Volker Neumann; Stefan Löseke; Dennis Nowak; Felix J F Herth; Andrea Tannapfel
Journal:  Dtsch Arztebl Int       Date:  2013-05-03       Impact factor: 5.594

View more
  3 in total

1.  Leukocytoclastic vasculitis as a cutaneous paraneoplastic syndrome in malignant mesothelioma.

Authors:  Hyeok-Jin Kwon; Kyung-Deok Park; Jung-Ho Yoon
Journal:  JAAD Case Rep       Date:  2022-06-19

2.  Concomitant Nephrotic Syndrome and Cryoglobulinemia in a Case of Malignant Mesothelioma.

Authors:  Kei Nagai; Hiroaki Tachi; Kohei Inoue; Atsushi Ueda
Journal:  Case Rep Nephrol       Date:  2022-09-28

3.  Secondary Minimal Change Disease Due to Pancreatic Cancer Improved by Chemotherapy.

Authors:  Sakue Masuda; Kazuya Koizumi; Hidekazu Moriya; Takashi Nishino; Haruki Uojima; Tomohiko Tazawa; Karen Kimura; Junichi Tasaki; Chikamasa Ichita; Akiko Sasaki; Makoto Kako; Sumi Hidaka; Madoka Kudo
Journal:  Intern Med       Date:  2020-09-19       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.